BioClec

Pioneering microglial therapies for Alzheimer's disease

BioClec was founded in 2025, is headquartered in Milan, Italy, lists 1–10 employees, and has 1 recorded funding round.

Headquarters
Milan
Employees
1–10
Founded
2025
Business Model
B2B
Last Round
SeedMar 2025
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

BioClec is a Milan, Italy-based biotechnology company launched in March 2025, focused on developing pioneering therapies for Alzheimer's disease. Emerging from Sofinnova Partners' 165M euro Biovelocita II accelerator program, BioClec targets microglia — the brain's critical immune cell population — to develop disease-modifying interventions via a novel microglial pathway. The company was co-founded by Dr. Marco Colonna, a global expert in neuroimmunology and Professor of Pathology & Immunology at Washington University School of Medicine, and is led by CEO Gabriella Camboni.

Summary

BioClec is a Biotech company based in Milan, Italy, founded in 2025. It lists 1–10 employees. Its most recent funding was a Seed round in Mar 2025. Investors include Sofinnova Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2025

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioClec on Indexed.vc
<a href="https://indexed.vc/companies/bioclec"><img src="https://indexed.vc/api/badge/company/bioclec" alt="BioClec on Indexed.vc" width="260" height="76" /></a>